AI / data analytics / healthtech / informatics

Luchen Li, wearing the sensor suit, and Professor Aldo Faisal.
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Clinical trials #Imperial College London #Movement disorders #Rare disease #Wearable tech

AI and wearable tech could speed up drug development

A multi-disciplinary team of researchers has developed a way to monitor the progression of movement disorders using motion capture technology and AI.   By combining human movement data gathered from wearable tech with a powerful new medical AI technology, the team were able to significantly increase the efficiency… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trial design #Funding #Psychedelics #Start-ups

What will the 2023 drug discovery landscape look like?

Listen to this article on the DDW podcast: DDW Multimedia Editor Megan Thomas observes the 2023 drug discovery landscape, speaking to industry experts and looking at the foundations of 2022 on which next year will lean. Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily… Read More

#Exclusive Content #Trends & Analysis

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Covid-19 #Immunology / Virology & Vaccines

AI use in repurposing drugs for Covid-19

Listen to this article on the DDW podcast: In 2020, AI models predicted the efficacy of repurposed drugs for Covid-19. Clinical trials revealed eight out of nine predictions were correct. Here Imran S Haque, VP Data Science at Recursion describes the journey of the AI platform behind… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Labforward #Laboratory #Laboratory data #Laboratory of the Future

The road to laboratory connectivity: Expectations, challenges & opportunities

This paid-for advertorial by Labforward appeared in DDW Volume 24 – Issue 1, Winter 2022/2023 Organisation leaders are facing ever-increasing pressures to digitise and future-proof their laboratories. The journey, however, to connecting a laboratory’s data, devices and people can be convoluted, particularly without the careful selection of solutions and tools… Read More

#Exclusive Content

Lab of the future
#AI / data analytics / healthtech / informatics #Events #Lab automation #Lab of the future

2023 event will prepare delegates for the lab of the future

Future Labs Live will be held at the Congress Center in Basel, Switzerland from May 31 to June 2. The organiser hopes to bring together practitioners, technicians, scientists, innovators, start-ups, and the vendor community all in one place. According to the organiser: “Future Labs LIVE is essential… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer drug targets #Cancer research #Collaboration #Oncology #Partnership

AI-powered cancer simulations enable drug targeting

Cancer Research Horizons and biotech company Turbine have announced a partnership to solve complex diseases.   The partnership will utilise Turbine’s Simulated Cells platform to identify target patient populations who could benefit from CDC7 inhibitor therapy with Cancer Research Horizons’ lead compound CRT’2199.   CRT’2199 originates from… Read More

#Business & Investment #Cancer Research #News

#AI / data analytics / healthtech / informatics #Data management #Data standardisation #EMA #FDA #Regulatory #Trial data

Driving enhanced patient outcomes through data standardisation 

Greater data-centricity, supported by new technologies, is key to driving efficient product approvals and supply chains. Frits Stulp and Aida Demneri, partners at Deloitte (including Iperion – a Deloitte business), outline how life sciences companies can play their part in driving change. In the past two years, EU… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Computer modelling #DEL #DNA #Drug discovery #Library screening #Target identification

New trends in DNA-encoded library screening

Matthew Clark, CEO of X-Chem, looks at what the future could hold for DNA-encoded library (DEL) technology. In the 13 years since it was first described, DNA-encoded library (DEL) technology has become a firmly established approach to small molecule hit generation in drug discovery. Most major pharma companies operate DEL… Read More

#Exclusive Content #Trends & Analysis

#AI / data analytics / healthtech / informatics #Biomarkers #Data management #Drug discovery #Life sciences #RNA sequencing

The latest drug discovery product launches

Several new products for the life sciences sector have been launched over the last month, from biomarker kits to video-based training platforms. DDW provides an update.  Breath Biopsy VOC Atlas – Owlstone Medical  The Breath Biopsy VOC Atlas is a catalogue of validated and quantitated… Read More

#Editor's Choice #News

Baby on a respirator - RSV
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Covid-19 #Immunology / Virology & Vaccines #Influenza #OneThree #Poolbeg Pharma #Respiratory syncytial virus

AI identifies drug candidates for respiratory syncytial virus

Potential new drug candidates have been identified by a respiratory syncytial virus (RSV) artificial intelligence programme, as health officials warn of a “tripledemic” of SARS-CoV-2, influenza and RSV.  The AI programme, part of a collaboration between Poolbeg Pharma and OneThree, uses Poolbeg’s RSV human challenge… Read More

#Editor's Choice #News

Protein
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #BioInnovation Institute #Biologics / Biotechnology #Investment #Proteins #Start-ups

Therapeutic protein project joins Bio Studio programme

A project creating a new class of therapeutic proteins to modulate cell signalling has been accepted into the BioInnovation Institute (BII) Bio Studio programme. The project is based on recent breakthroughs in artificial intelligence (AI) and protein design, and uses methods pioneered by David Baker’s laboratory at the University of… Read More

#News #Start-up Zone

#AI / data analytics / healthtech / informatics #Biologics / Biotechnology #Biopharmaceuticals #Cell and gene therapy #Diversity #Market reporting #Mergers and acquisitions #Personalised medicine #Pharmaceutical industry #Precision medicine

Drug discovery in 2023: Five key predictions

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023.  1. There will be greater emphasis on diversity… Read More

#Exclusive Content #Trends & Analysis

Drug screening in laboratory
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Collaboration #Drug targets #High throughput screening #Partnership #Phenotyping #PhoreMost #ThinkCyte

New research collaboration to advance AI based drug discovery

PhoreMost and ThinkCyte have entered a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI).  The partnership leverages both companies’ technologies in high-throughput drug discovery, PhoreMost’s phenotypic screening platform, SITESEEKER, and ThinkCyte’s AI-driven cell characterisation and sorting platform, Ghost Cytometry. … Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trials #Covid-19 #Drug development #Healthcare #Public health #Regulatory

Drug development practices to improve public health policy 

Dr Andrew Garrett, Executive Vice President of Scientific Operations at ICON, explores the benefits of integrating some of the validation and standardisation practices already developed for PIs into the practices around NPIs and public health data; outlines some of the practices that can be implemented in order to do this;… Read More

#Exclusive Content #Opinion #Regulatory

#AI #AI / data analytics / healthtech / informatics #Collaboration #Genetics / genomics #Neurodevelopmental disorders #Neurology #Precision medicine #Rare disease

Partnership hopes to advance precision drug development

A new partnership between industry and three rare disease foundations has formed with the goal of accelerating the development of precision drugs to treat rare neurodevelopmental disorders.  AI-driven genomics company Genomenon will partner with COMBINEDBrain, SynGAP Research Fund, and SLC-6A1 Connect and their pharma partners to deliver… Read More

#News

#AI / data analytics / healthtech / informatics #Life sciences #Pistoia Alliance #R&D #Real world data #Technology

Social media project will drive patient centricity in drug development  

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join… Read More

#News